Researchers Unravel Mystery Behind Deadly Brain Disorder

Researchers have now identified a genetic cause behind some of these cases, offering longawaited answers to affected families. A study published in Genome Medicine links changes in a gene called VPS25 to a previously unknown brain disorder, giving doctors a new way to investigate severe neurological conditions that have remained unexplained. Five families reveal a shared genetic clue The discovery began with a pattern of illness shared by children from five unrelated families across Saudi Arabia, Europe, and North America. Three families were initially identified through genomic programs in Saudi Arabia, and researchers subsequently connected their cases with others overseas. Although the families were unrelated, their children had similar symptoms and changes in the same gene. “When a condition is this rare, one family alone may not be enough to reveal what is happening.
“Bringing together clinical experience with genomic data from Saudi Arabia, and connecting it with cases internationally, allowed us to see a pattern that had previously been invisible. This is why building these genomic resources matters: they can help us find answers to diseases that might otherwise remain unexplained,” said Professor Fowzan Alkuraya, clinical genetics lead on the study who is affiliated with both King Faisal Specialist Hospital and Research Centre (KFSHRC) and King Abdullah University of Science and Technology (KAUST). To understand how these genetic changes might affect the developing brain, scientists at KAUST examined biological processes inside affected cells.
The VPS25 gene plays a role in maintaining nerve cells, and laboratory testing revealed disruptions that altered both the number and contents of tiny packages released by cells. Some of these packages were missing proteins involved in protecting and maintaining nerve cells, offering clues about how the disorder develops. The findings provide the first evidence connecting VPS25 changes to a human disease. Establishing that connection required clinicians at KFSHRC to work closely with affected families, documenting their symptoms and investigating possible genetic causes, while KAUST researchers studied the underlying cellular problems.
For families who have endured years of uncertainty, identifying the cause offers something that was previously missing: an explanation for their children’s illness and information that could help guide future pregnancy decisions. The discovery also gives clinicians a new gene to examine when investigating similar brain abnormalities and may allow the condition to be detected through genetic testing during pregnancy. “Knowing that this disease has a rare genetic cause can bring comfort to families who have lived for years with uncertainty about their tragic losses.
“It also enables clinicians around the world to recognize similar cases and detect the disease through genetic testing during pregnancy,” said Professor Jasmeen Merzaban, co-lead of the study at KAUST. Researchers hope that identifying VPS25 as a disease-associated gene will help uncover additional cases around the world. Studying more affected families could reveal how the condition varies between children, improve diagnosis and genetic counseling, and provide a clearer understanding of how disruptions involving VPS25 interfere with early brain development.



